REGISTERED
on 23 Apr 2024
Last Applicant/ Owned by
Nottingham NG2 3ED
GB
Serial Number
79345867 filed on 26th May 2022
Registration Number
7362015 registered on 23rd Apr 2024
Correspondent Address
Karen Lim Fross Zelnick Lehrman & Zissu, P.C.
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
RECOMBUMIN
Chemicals used in industry, science and for use in the manufacture of pharmaceuticals; chemical reagents other than for medical or veterinary purposes; diagnostic reagents and preparations, other than for medical or veterinary purposes; chemical excipients for use in the manufacture of pharmaceutical preparations; proteins for industrial purposes; recombinant human albumin for use as a stabilizer Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceuticals for the treatment or prophylaxis of viral, bacterial, fungal, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, neurodegenerative, neuromuscular, central nervous system, gastrointestinal, hormonal, dermatological, psychiatric, immune system, urinary, angiogenic, genetic, menopausal, and pain related diseases and disorders; pharmaceutical products and substances for the treatment or prophylaxis of viral, bacterial, fungal, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, neurodegenerative, neuromuscular, central nervous system, gastrointestinal, hormonal, dermatological, psychiatric, immune system, urinary, angiogenic, genetic, menopausal, and pain related diseases and disorders; albumin, chemical preparations, synthetic peptides, protein supplements, monoclonal, polyclonal, immunological, native and recombinant antibodies for medical and veterinary use, cells for medical and veterinary use, viruses, live viruses, live- attenuated viruses, attenuated viruses, and virus-like particles and viral vectors for medical and veterinary use, vaccines, growth factors for medical and veterinary use, immune modulators for medical and veterinary use, monoclonal antibodies, biological tissue and tissue cultures, recombinant proteins for medical and veterinary use, nucleic acid sequences, blood plasma, blood components for medical and veterinary use, all being for pharmaceutical use for the treatment or prophylaxis of viral, bacterial, fungal, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, respiratory, digestive, neurological, neurodegenerative, neuromuscular, central nervous system, gastrointestinal, hormonal, dermatological, psychiatric, immune system, urinary, angiogenic, genetic, menopausal, and pain related diseases and disorders; reagents for medical use; diagnostic reagents for medical use; protein supplements for pharmaceutical purposes; albuminous preparations for medical or veterinary purposes; recombinant albumin for biological therapeutic purposes
First Use Date in General
11th 000101
First Use Date in Commerce
11th 000101
Class [001]
Chemical Products
Chemicals used in industry, science and for use in the manufacture of pharmaceuticals; chemical reagents other than for medical or veterinary purposes; diagnostic reagents and preparations, other than for medical or veterinary purposes; chemical excipients for use in the manufacture of pharmaceutical preparations; proteins for industrial purposes; recombinant human albumin for use as a stabilizer and excipient for industrial purposes and for use in the manufacture of cell culture media, cell and tissue storage and preservation media and for the manufacture of diagnostic imaging agents; cell culture reagents for scientific and research use, and chemical preservation reagents for scientific and research use; albumin for use in the manufacture of pharmaceutical products, vaccines, cellular therapies, regenerative medicines and gene therapies; protein in raw material form for scientific and medical research
First Use Date in General
11th 000101
First Use Date in Commerce
11th 000101
Mark Details
Serial Number
No 79345867
Mark Type
No Service/Collective Mark
Attorney Docket Number
No ALBU 2308202
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 23rd Apr 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 23rd Apr 2024 | REGISTERED-PRINCIPAL REGISTER |
| 06th Feb 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 06th Feb 2024 | PUBLISHED FOR OPPOSITION |
| 05th Feb 2024 | NOTIFICATION PROCESSED BY IB |
| 17th Jan 2024 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| 17th Jan 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 17th Jan 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 13th Jan 2024 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| 31st Dec 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |